Dr. Patrick Daniel McAuliffe, MD

Dr. McAuliffe practices at Touro Infirmary in New Orleans, Louisiana, part of LCMC Health.

Dr. McAuliffe's NPI, 1093976961, was assigned on June 23, 2008. Dr. McAuliffe graduated from University of South Alabama College of Medicine in 2008. Dr. McAuliffe holds Louisiana license MD.205628.

Dr. McAuliffe's primary practice is Touro Infirmary, at 1401 Foucher Street, New Orleans, LA 70115 in Orleans Parish. The practice phone is (504) 897-8247.

Dr. McAuliffe's primary practice is Touro Infirmary in New Orleans, Louisiana, part of LCMC Health. The medical group on file is Schumacher Clinical Partners. Dmand AI also links Dr. McAuliffe to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McAuliffe practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. McAuliffe's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. McAuliffe is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. McAuliffe is licensed in Louisiana.

CMS data shows 216 Medicare services from Dr. McAuliffe across 4 procedure codes in 2024, for 147 Medicare patients. Medicare paid $20,614 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 147 Medicare patients who saw Dr. McAuliffe in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McAuliffe's median patient age at 62, with 64% women.

In 2024, Dr. McAuliffe wrote 145 Medicare Part D claims for 115 patients. 90% of them were for generic drugs. CMS names the drug for 65 of them, across 5 drugs with 11 or more claims each, at $357 in total drug cost. In 2023, CMS named 59 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. McAuliffe for performance year 2024, reported as part of a group. Dr. McAuliffe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. McAuliffe from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 93% of the total. Edwards Lifesciences Corporation paid the most, $550.

Dr. McAuliffe graduated from University of South Alabama College of Medicine in 2008.